Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 Jun 1;178(6):802-809.
doi: 10.1001/jamainternmed.2018.0447.

Association of a Smartphone Application With Medication Adherence and Blood Pressure Control: The MedISAFE-BP Randomized Clinical Trial

Kyle Morawski  1   2 , Roya Ghazinouri  1 , Alexis Krumme  1 , Julie C Lauffenburger  1 , Zhigang Lu  1 , Erin Durfee  3 , Leslie Oley  3 , Jessica Lee  1 , Namita Mohta  1 , Nancy Haff  1 , Jessie L Juusola  3 , Niteesh K Choudhry  1
Affiliations
Randomized Controlled Trial

Association of a Smartphone Application With Medication Adherence and Blood Pressure Control: The MedISAFE-BP Randomized Clinical Trial

Kyle Morawski et al. JAMA Intern Med. .

Erratum in

  • Missing Acknowledgment.
    [No authors listed] [No authors listed] JAMA Intern Med. 2018 Jun 1;178(6):876. doi: 10.1001/jamainternmed.2018.2297. JAMA Intern Med. 2018. PMID: 29799946 Free PMC article. No abstract available.

Abstract

Importance: Medication nonadherence accounts for up to half of uncontrolled hypertension. Smartphone applications (apps) that aim to improve adherence are widely available but have not been rigorously evaluated.

Objective: To determine if the Medisafe smartphone app improves self-reported medication adherence and blood pressure control.

Design, setting, and participants: This was a 2-arm, randomized clinical trial (Medication Adherence Improvement Support App For Engagement-Blood Pressure [MedISAFE-BP]). Participants were recruited through an online platform and were mailed a home blood pressure cuff to confirm eligibility and to provide follow-up measurements. Of 5577 participants who were screened, 412 completed consent, met inclusion criteria (confirmed uncontrolled hypertension, taking 1 to 3 antihypertensive medications), and were randomized in a ratio of 1:1 to intervention or control.

Interventions: Intervention arm participants were instructed to download and use the Medisafe app, which includes reminder alerts, adherence reports, and optional peer support.

Main outcomes and measures: Co-primary outcomes were change from baseline to 12 weeks in self-reported medication adherence, measured by the Morisky medication adherence scale (MMAS) (range, 0-8, with lower scores indicating lower adherence), and change in systolic blood pressure.

Results: Participants (n = 411; 209 in the intervention group and 202 controls) had a mean age of 52.0 years and mean body mass index, calculated as weight in kilograms divided by height in meters squared, of 35.5; 247 (60%) were female, and 103 (25%) were black. After 12 weeks, the mean (SD) score on the MMAS improved by 0.4 (1.5) among intervention participants and remained unchanged among controls (between-group difference: 0.4; 95% CI, 0.1-0.7; P = .01). The mean (SD) systolic blood pressure at baseline was 151.4 (9.0) mm Hg and 151.3 (9.4) mm Hg, among intervention and control participants, respectively. After 12 weeks, the mean (SD) systolic blood pressure decreased by 10.6 (16.0) mm Hg among intervention participants and 10.1 (15.4) mm Hg among controls (between-group difference: -0.5; 95% CI, -3.7 to 2.7; P = .78).

Conclusions and relevance: Among individuals with poorly controlled hypertension, patients randomized to use a smartphone app had a small improvement in self-reported medication adherence but no change in systolic blood pressure compared with controls.

Trial registration: clinicaltrials.gov Identifier: NCT02727543.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure 1.
Figure 1.. CONSORT Diagram
Figure 2.
Figure 2.. Change in Adherence Category From Baseline to 12 Weeks of Follow-up
See this image and copyright information in PMC

Comment in

References

    1. Benjamin EJ, Blaha MJ, Chiuve SE, et al. ; American Heart Association Statistics Committee and Stroke Statistics Subcommittee . Heart Disease and Stroke Statistics-2017 Update: a report from the American Heart Association. Circulation. 2017;135(10):e146-e603. - PMC - PubMed
    1. Booth JN III, Muntner P, Abdalla M, et al. . Differences in night-time and daytime ambulatory blood pressure when diurnal periods are defined by self-report, fixed-times, and actigraphy: Improving the Detection of Hypertension study. J Hypertens. 2016;34(2):235-243. - PMC - PubMed
    1. de Oliveira-Filho AD, Costa FA, Neves SJ, de Lyra Junior DP, Morisky DE. Pseudoresistant hypertension due to poor medication adherence. Int J Cardiol. 2014;172(2):e309-e310. - PubMed
    1. Rehman H, Kamal AK, Morris PB, Sayani S, Merchant AT, Virani SS. Mobile Health (mHealth) technology for the management of hypertension and hyperlipidemia: slow start but loads of potential. Curr Atheroscler Rep. 2017;19(3):12. - PubMed
    1. Buis L, Hirzel L, Dawood RM, et al. . Text messaging to improve hypertension medication adherence in African Americans from primary care and emergency department settings: results from two randomized feasibility studies. JMIR Mhealth Uhealth. 2017;5(2):e9. - PMC - PubMed

Publication types

Substances

Associated data